Home
About
Overview
Sharing Data
ORCID
Help
History (6)
Dose-escalation trial of the ALK, MET & ROS1 inhibitor, crizotinib, in patients with advanced cancer.
Nanoengineering Solutions for Cancer Therapy: Bridging the Gap between Clinical Practice and Translational Research.
Systemic therapies in the treatment of non-small-cell lung cancer brain metastases.
Topographic mapping of the EEG in premature infants and neonates.
Molecular biomarkers for future screening of lung cancer.
See All 6 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Molecular biomarkers for future screening of lung cancer.
Molecular biomarkers for future screening of lung cancer. J Surg Oncol. 2013 Oct; 108(5):327-33.
View in:
PubMed
subject areas
Biomarkers, Tumor
Breath Tests
Early Detection of Cancer
Humans
Lung Neoplasms
Tomography, X-Ray Computed
authors with profiles
Clarissa C. Parker
Ravi Salgia
Thomas Hensing